FDA全球物质注册数据库(FDA Global Substance Registration System)
检索条件:" RN=2283356-12-5"
物质名称 CAS登记号 物质唯一标识 分子式 异名/同义词
LENACAPAVIR SODIUM 2283356-12-5 BDT58WJ9WE BDT58WJ9WE 1H-CYCLOPROPA(3,4)CYCLOPENTA(1,2-C)PYRAZOLE-1-ACETAMIDE, N-((1S)-1-(3-(4-CHLORO-3-((METHYLSULFONYL)AMINO)-1-(2,2,2-TRIFLUOROETHYL)-1H-INDAZOL-7-YL)-6-(3-METHYL-3-(METHYLSULFONYL)-1-BUTYN-1-YL)-2-PYRIDINYL)-2-(3,5-DIFLUOROPHENYL)ETHYL)-5,5-DIFLUORO-3B,4,4A,5-TETRAHYDRO-3-(TRIFLUOROMETHYL)-, SODIUM SALT (1:1), (3BS,4AR)-
GS-6207-02
GS-HIV SODIUM
LENACAPAVIR SODIUM
LENACAPAVIR SODIUM [USAN]
LENACAPAVIR SODIUM [WHO-DD]
N-((1S)-1-(3-(4-CHLORO-3-(METHANESULFONAMIDO)-1-(2,2,2-TRIFLUOROETHYL)-1H-INDAZOL-7-YL)-6-(3-(METHANESULFONYL)-3-METHYLBUT-1-YN-1-YL)PYRIDIN-2-YL)-2-(3,5-DIFLUOROPHENYL)ETHYL)-2-((3BS,4AR)-5,5-DIFLUORO-3-(TRIFLUOROMETHYL)-3B,4,4A,5-TETRAHYDRO1H-CYCLOPROPA(3,4)CYCLOPENTA(1,2-C)PYRAZOL-1-YL)ACETAMIDE, SODIUM SALT (1:1)
SUNLENCA
YEZTUGO
英文物质名称,关联名称搜索 高级检索
©2006-2026 Drugfuture->FDA Global Substance Registration System